Clinical Trials Browser

Phase 1 × Recruiting × Solid Tumor × Clear all

NCT06874335 2026-05-13

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06014502 2026-05-08

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06619587 2026-05-04

A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06349837 2026-05-01

Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06132828 2026-04-27

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06297525 2026-04-23

Study of STP938 in Advanced Solid Tumours

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06576037 2026-04-16

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06718621 2026-04-14

A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05238792 2026-03-12

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06563375 2026-03-12

Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05661201 2026-03-06

NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06809114 2026-01-30

FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06644300 2026-01-29

Study of BM230 in Patients With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT07275242 2026-01-15

A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06816108 2026-01-12

A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors

Phase 1 Recruiting

Other solid neoplasmThoracic

Solid Tumor

NCT06368921 2025-12-30

A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06797336 2025-12-18

A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05522868 2025-11-20

SB17170 Phase 1 Clinical Trial in Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06241898 2025-09-26

A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06475131 2025-09-18

A Study of BL-B16D1 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT04064359 2025-09-16

Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT07098052 2025-08-01

A Study of HDM2020 in Patients With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05217693 2025-07-24

A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06894745 2025-07-22

PET [89Zr]DFO-starPEG in Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06883149 2025-06-10

PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05749432 2025-04-18

A Phase I Study of Hemay181 in Patients With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06046742 2025-03-13

A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05907980 2025-03-06

A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT03891706 2024-09-19

Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06589401 2024-09-19

Oral Paclitaxel for Patients with Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT04928612 2024-08-28

A Study of CBP-1018 in Patients With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05244551 2024-08-12

A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06410092 2024-05-10

Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06086522 2024-05-01

Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06394622 2024-05-01

A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06342336 2024-04-02

HS-IT101 Injection in the Treatment of Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06101082 2024-03-06

A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06166888 2024-01-17

A Study of AK131 in Patients With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06209385 2024-01-17

A Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05940896 2023-11-27

RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 Expression

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor